About IAC
A-Z Index
Immunization Action Coalition

Vaccine-Related Journal Articles

Diseases and Vaccines: Shingles (zoster)

Shingles (zoster) 2015-2013
Vaccination Coverage among Adults, Excluding Influenza Vaccination—United States, 2013
Source: MMWR, February 6, 2015, Vol 64(04):95-102
Closure of Varicella-Zoster Virus–Containing Vaccines Pregnancy Registry—United States, 2013
Source: MMWR, August 22, 2014, Vol. 63(33):732-3
Update on Recommendations for Use of Herpes Zoster Vaccine
Source: MMWR, August 22, 2014, Vol. 63(33):729-31
Relationship of Income and Health Care Coverage to Receipt of Recommended Clinical Preventive Services by Adults—United States, 2011–2012
Source: MMWR, August 9, 2014, Vol. 63(31):666-70
Noninfluenza Vaccination Coverage among Adults—United States, 2012
Source: MMWR, February 7, 2014, Vol. 63(05):95-102
Examination of Links between Herpes Zoster Incidence and Childhood Varicella Vaccination
Authors: Hales CM, Harpaz R, Joesoef MR, Bialek SR
Source: Ann Intern Med, December 3, 2013, Vol. 159(11):739-45
Varicella Zoster Virus-Specific Immune Responses to a Herpes Zoster Vaccine in Elderly Recipients with Major Depression and the Impact of Antidepressant Medications
Authors: Irwin MR, Levin MJ, Laudenslager ML, et al
Source: Clin Infect Dis, April 2013, Vol. 56(8):1085-93
Noninfluenza Vaccination Coverage among Adults — United States, 2011
Source: MMWR, February 1, 2013, Vol. 62(04):66-72
Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-Herpetic Neuralgia in an Older US Population: A Cohort Study
Authors: Langan SM, Smeeth L, Margolis DJ, Thomas SL
Source: PLoS Med, 2013, Vol. 10(4):e1001420
Shingles (zoster) 2012
Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy
Authors: Schmader KE, Oxman MN, Levin MJ, et al.
Source: Clin Infect Dis, November 15, 2012, Vol. 55(10):1320-8
Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50–59 Years
Authors: Schmader KE, Levin MJ, Gnann JW Jr, et al.
Source: Clin Infect Dis, April 1, 2012, Vol. 54(7):922-8
Adult Vaccination Coverage--United States, 2010
Source: MMWR, February 3, 2012, Vol. 61(04):66-72
Update on Adult Immunizations
Author: Wolfe RM
Source: J Am Board Fam Med, 2012, Vol. 25(4):496-510
Available online at: www.jabfm.org/content/25/4/496.full
Shingles (zoster) 2011
Update on Herpes Zoster Vaccine: Licensure for Persons Aged 50 through 59 Years
Source: MMWR, November 11, 2011, Vol. 60(44):1528
Barriers to the Use of Herpes Zoster Vaccine
Authors: Hurley LP, Lindley MC, Harpaz R, et al.
Source: Ann Intern Med, May 4, 2011, Vol. 152(9):555-60
Herpes Zoster Vaccination among Adults Aged 60 Years and Older, in the U.S., 2008
Authors: Lu PJ, Euler GL, Harpaz R
Source: Am J Prev Med, February 2011, Vol. 40(2):e1-6
Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease
Authors: Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ
Source: JAMA, January 12, 2011, Vol. 305(2):160-6
Shingles (zoster) 2010
Safety, Tolerability, and Immunogenicity of Zoster Vaccine in Subjects with a History of Herpes Zoster
Authors: Mills R, Tyring SK, Levin MJ, et al.
Source: Vaccine, April 20, 2010
Modeling the Impact of One- and Two-Dose Varicella Vaccination on the Epidemiology of Varicella and Zoster
Authors: Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P
Source: Vaccine, March 1, 2010
Shingles Vaccine
Authors: Willison CB, Morrison LK, Mendoza N, Tyring SK
Source: Expert Opin Biol Ther, January 3, 2010
Shingles (zoster) 2009
The Incidence and Clinical Characteristics of Herpes Zoster among Children and Adolescents after Implementation of Varicella Vaccination
Authors: Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF
Source: Pediatr Infect Dis J, November 2009, Vol. 28(11):954-9
Incidence of Herpes Zoster among Children Vaccinated with Varicella Vaccine in a Prepaid Health Care Plan in the United States, 2002-2008
Authors: Tseng HF, Smith N, Marcy SM, Sy LS, Jacobsen SJ
Source: Pediatr Infect Dis J, September 19, 2009
Immunization Programs for Infants, Children, Adolescents, and Adults: Clinical Practice Guidelines by the Infectious Diseases Society of America
Authors: Pickering LK, Baker CJ, Freed GL, et al.
Source: Clin Infect Dis, September 15, 2009, Vol. 49(6):817-40
A 70-Year-Old Woman with Shingles
Author: Whitley RJ
Source: JAMA, July 1, 2009, Vol. 302(1):73-80
Herpes Zoster (Shingles) and Postherpetic Neuralgia
Authors: Sampathkumar P, Drage LA, Martin DP
Source: Mayo Clin Proc, March 2009, Vol. 84(3):274-80
Herpes Zoster Vaccination among Adults Aged 60 Years or Older in the United States, 2007: Uptake of the First New Vaccine to Target Seniors
Authors: Lu PJ, Euler GL, Jumaan AO, Harpaz R
Source: Vaccine, February 5, 2009, Vol. 27(6):882-7
Retrospective Financial Analysis of a Herpes Zoster Vaccination Program from an Independent Community Pharmacy Perspective
Authors: Wood HM, McDonough RP, Doucette WR
Source: J Am Pharm Assoc (2003), January-February 2009, Vol. 49(1):12-7
back to top
Shingles (zoster) 2008
Herpes Zoster-Related Hospitalizations and Expenditures Before and After Introduction of the Varicella Vaccine in the United States
Authors: Patel MS, Gebremariam A, Davis MM
Source: Infect Control Hosp Epidemiol, December 2008, Vol. 29(12):1157-63
Hospitalizations to Treat Herpes Zoster in Older Adults: Causes and Validated Rates
Authors: Jackson LA, Reynolds MA, Harpaz R
Source: Clin Infect Dis, September 15, 2008, Vol. 47(6):754-9
Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Authors: Centers for Disease Control and Prevention
Source: MMWR, June 6, 2008, Vol. 57(RR-5)
Varicella-Zoster Virus-Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine
Authors: Levin MJ, Oxman MN, Zhang JH
Source: J Infect Dis, March 15, 2008, Vol. 197(6):825-35
The Impact of the Varicella Vaccination Program on Herpes Zoster Epidemiology in the United States: A Review
Authors: Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF
Source: J Infect Dis, March 1, 2008, Vol.197 Suppl 2:S224-7
Vaccination against Herpes Zoster and Postherpetic Neuralgia
Authors: Oxman MN, Levin MJ; Shingles Prevention Study Group
Source: J Infect Dis, March 1, 2008, Vol.197 Suppl 2:S228-36
National Survey of Primary Care Physicians Regarding Herpes Zoster and the Herpes Zoster Vaccine
Authors: Hurley LP, Harpaz R, Daley MF, et al.
Source: J Infect Dis, March 1, 2008, Vol.197 Suppl 2:S216-23
The Epidemiological, Clinical, and Pathological Rationale for the Herpes Zoster Vaccine
Authors: Schmader K, Gnann JW Jr, Watson CP
Source: J Infect Dis, March 1, 2008, Vol.197 Suppl 2:S207-15
Risk of Herpes Zoster in Adults Immunized with Varicella Vaccine
Authors: Hambleton S, Steinberg SP, Larussa PS, Shapiro ED, Gershon AA
Source: J Infect Dis, March 1, 2008, Vol.197 Suppl 2:S196-9
Primary Varicella and Herpes Zoster among HIV-Infected Children from 1989 to 2006
Authors: Wood SM, Shah SS, Steenhoff AP, Rutstein RM
Source: Pediatrics, January 2008, Vol. 121(1):e150-6
back to top
Shingles (zoster) 2007
Clinical Diagnosis of Herpes Zoster in Family Practice
Authors: Opstelten W, van Loon AM, Schuller M, et al
Source: Ann Fam Med, July-August 2007; 5(4):305-309
Herpes Zoster
Authors: Wareham DW, Breuer J
Source: BMJ, June 9, 2007; 334(7605):1211-1215
Chickenpox Exposure and Herpes Zoster Disease Incidence in Older Adults in the U.S.
Authors: Chaves SS, Santibanez TA, Gargiullo P, Guris D
Source: Public Health Reports, March-April 2007; 122:155-159
Varicella-Zoster Vaccine for the Prevention of Herpes Zoster
Authors: Kimberlin DW, Whitley RJ
Source: N Engl J Med, March 29, 2007; 356(13):1338-1343
Recommendations for the Management of Herpes Zoster
Authors: Dworkin RH, Johnson RW, Breuer J, et al
Source: Clin Infect Dis, January 1, 2007; 44 (Suppl 1):S1-S26.
back to top
Shingles (zoster) 2006
General Recommendations on Immunization
Source: MMWR, December 1, 2006; 55(RR-15):1-48
HTML |  PDF (entire issue)
Interleukin-2: A Potential Treatment Option for Postherpetic Neuralgia?
Authors: Rotty J, Heinzerling L, Schurmann D, Suttorp N
Source: Clin Infect Dis, December 15, 2006; 43(12):e109-110
Provisional ACIP Recommendations: Use of zoster [shingles] vaccine
Centers for Disease Control and Prevention, November 20, 2006
Herpes Zoster Vaccine (Zostavax)
Source: Med Lett Drugs Ther, September 11, 2006, Vol. 48(1243):73-74
Cost-Effectiveness of a Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Authors: Hornberger J, Robertus K
Source: Ann Intern Med, September 5, 2006, Vol. 145(5):317-325
Shingles Vaccine: Effective and Costly or Cost-Effective?

Author: Koplan JP
Source: Ann Intern Med, September 5, 2006, Vol. 145(5):386-387
Prevention of Shingles by Varicella Zoster Virus Vaccination
Author: Holodniy M
Source: Expert Review of Vaccines, August 2006; 5(4):431-443
Herpes Zoster and Its Cardiovascular Complications in the Elderly - Another Look at a Dormant Virus
Authors: Ma TS, Collins TC, Habib G, Bredikis A, Carabello BA
Source: Cardiology, June 7, 2006, Vol. 107(1):63-67
Shingles, the Return of the Chickenpox Virus
Source: Mayo Clin Womens Healthsource, June 2006, Vol. 10(6):6
Varicella-Zoster Virus Vaccine: A Review of Its Use in the Prevention of Herpes Zoster in Older Adults
Author: Caple J
Source: Drugs Today (Barc), April 2006, Vol. 42(4):249-254
Shutting Down Shingles
Author: Snow M
Source: Nursing, April 2006, Vol. 36(4):18-19
Treatment of Herpes Zoster
Author: Holten KB
Source: Am Fam Physician, March 1, 2006, Vol. 73(5):882-884
Gender as an Independent Risk Factor for Herpes Zoster: A Population-Based Prospective Study
Authors: Opstelten W, Van Essen GA, Schellevis F, Verheij TJ, Moons K
Source: Ann Epidemiol, March 1, 2006 (Epub ahead of print)
The Burden of Herpes Zoster: A Prospective Population Based Study
Authors: Scott FT, Johnson RW, Leedham-Green M, et al
Source: Vaccine, February 27, 2006, Vol. 24(9):1308-1314
New Viral Vaccines
Authors: Arvin AM, Greenberg HB
Source: Virology, January 5, 2006, Vol. 344(1):240-249
back to top
Shingles (zoster) 2005
Herpes Zoster in Immunocompromised Patients: Incidence, Timing, and Risk Factors
Authors: Wung PK, Holbrook JT, Hoffman GS, et al
Source: Am J Med, December 2005, Vol. 118(12):1416
Infections in the Elderly
Author: Scheinfeld N
Source: Dermatol Online J, December 1, 2005 Vol. 11(3):8
Varicella Immunization and Herpes Zoster
Author: Volpi A
Source: Herpes, December 2005, Vol. 12(3):59
Viral Infections in the Elderly. The Challenges of Managing Herpes Zoster, Influenza, and RSV
Authors: Bader MS, McKinsey DS
Source: Postgrad Med, November 2005 Vol. 118(5):45-8, 51-54
The Growing Paradigm of Preventing Disease: Vaccines to Prevent Herpes Zoster and Pertussis in Adults
Author: Poland GA
Source: Ann Intern Med, October 4, 2005 143(7):539-541
Varicella Zoster Infection and Pulmonary Complications
Authors: Dahan E, Simsolo C, Merei M, et al
Source: Eur J Intern Med, October 16, 2005 (6):449-450
Herpes Zoster and Postherpetic Neuralgia: Prevention and Management
Authors: Mounsey AL, Matthew LG, Slawson DC
Source: Am Fam Physician, September 15, 2005, Vol. 72(6):1075-1080
These Shots Aren't Just Kid Stuff. Adults May Soon Be Rolling Up Their Sleeves to Get Vaccinated for Shingles and Whooping Cough
Source: Harv Health Lett, August 2005, Vol. 30(10):4-5
The Incidence of Herpes Zoster in a United States Administrative Database
Authors: Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA
Source: J Gen Intern Med, August 2005, Vol. 20(8):748-753
Experimental Shingles Vaccine Proves Effective in Nationwide Study
Source: FDA Consum, July-August, 2005, Vol. 39(4):7
Varicella-Zoster Virus Vaccine--Grown-ups Need It, Too
Author: Gilden DH
Source: N Engl J Med, June 2, 2005, Vol. 352(22):2344-2346
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Authors: Oxman MN, Levin MJ, Johnson GR, et al
Source: N Engl J Med, June 2, 2005, Vol. 352(22):2271-2284
Aging, Immunity, and the Varicella-zoster Virus
Author: Arvin A
Source: N Engl J Med, June 2, 2005, Vol. 352(22):2266-2267
The Incidence of Varicella and Herpes Zoster in Massachusetts as Measured by the Behavioral Risk Factor Surveillance System (BRFSS) During a Period of Increasing Varicella Vaccine Coverage, 1998-2003
Authors: Yih WK, Brooks DR, Lett SM, et al
Source: BMC Public Health, June 2005, Vol. 16;5(1):68
Incidence of Herpes Zoster, before and after Varicella-Vaccination-Associated Decreases in the Incidence of Varicella, 1992-2002
Authors: Jumaan AO, Yu O, Jackson LA, et al
Source: J Infect Dis, June 15, 2005, Vol. 191(12):2002-2007
Changing Dynamics of Varicella-Zoster Virus Infections in the 21st Century: the Impact of Vaccination
Author: Whitley RJ
Source: J Infect Dis, June 15, 2005, Vol. 191(12):1999-2001
back to top
Shingles (zoster) 2004-2000
Treatment of Postherpetic Neuralgia
Authors: Sra KK, Tyring SK
Source: Skin Therapy Lett October 2004, Vol. 9(8):1-4
The Incidence of Shingles and Its Implications for Vaccination Policy
Authors: Chapman RS, Cross KW, Fleming DM
Source: Vaccine, Jun 2, 2003, Vol. 21(19-20):2541-2547
History of Varicella Zoster Virus
Author: Wood MJ
Source: Herpes, October 2000, Vol. 7(3):60-65
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.